Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Current Blog Category: Gene Therapy
What Is Gene Editing? How It Works In 2-Minutes
Contributing Author : Gina Big Picture Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 – an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the…
Read MoreBiotech CEO Jeff Galvin Explains Cell and Gene Therapy to Stony Brook Biomedical Engineering Society
Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies (AGT), gives an inspiring talk at the Stony Brook University Biomedical Engineering Society (BMES) detailing his journey from working closely with computers in Silicon Valley to leveraging the progression of gene and cell…
Read MoreCovid-19 Testing Lab Self Swab Instructions – How to Self Test by American Gene Technologies
Subscribe to our YouTube Channel As the COVID-19 Pandemic continues to affect the nation, American Gene Technologies (AGT) developed its own coronavirus testing lab to ensure the health and safety of employees. Today, the tests are available to members of the community. In this video,…
Read MoreCOVID-19 PRC Testing Lab at American Gene Technologies
Subscribe to our YouTube Channel As the COVID-19 Pandemic continues across the globe, Jeff Galvin, CEO of American Gene Technologies (AGT), explains the measures AGT has taken to keep employees protected. AGT developed its own COVID-19 testing lab using high accuracy RT-PCR tests. These tests…
Read MoreTechnology Transfer, A Catalyst For Gene Therapy Startups | The Spark Therapeutics Example
Contributing Author: Gina Hagler The ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline. Traditionally, pharmaceutical companies have developed small molecule medicines such as Zantac or Lipitor to treat conditions…
Read MoreWhat Is Gene Therapy? How It Works In 2-Minutes
Contributing Author: Gina Hagler Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing are all forms of genomic medicine1 – an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the…
Read MoreBiotech IPOs 2020 and M&A Trends
Contributing Author John Vandermosten, Senior Biotechnology Analyst Transaction Trends 2020 Life sciences transactions have boomed over the last year. Merger and acquisition (M&A) activity distinguished itself with several large and meaningful deals, but it was initial public offerings (IPOs) that stole the spotlight…
Read MoreRare Disease Moms Make Their Voices Heard | Three Inspirational Stories
Contributing Author: Gina Hagler There are 7,000 known rare diseases in the world. Each of them affects less than 1% of the global population, although ultra-rare diseases affect fewer still. The majority of rare and ultra-rare diseases are monogenic in nature, meaning they are caused…
Read More5 Ways Gene Therapy Companies are Transforming Rare Disease Cures
Contributing Author: Gina Hagler Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it difficult and expensive to bring together enough individuals for a clinical-stage trial. The small patient population of fewer than 1% of the population…
Read MoreA SPACtacular Way to Go Public
Contributing Author John Vandermosten, Senior Biotechnology Analyst What Is A SPAC Anyway? 2020 turned out to be a fantastic year for private companies to go public. In a hot year for initial public offerings (IPOs), one type of IPO called a Special Purpose Acquisition…
Read MoreSubscribe to Receive our Blog Updates
Subscribe to our blog updates to be notified when we release new content!